RemedyLogic AI MRI Lumbar Spine Reader
Remedy Logic Inc. • Radiology • 10/30/2024
Device Purpose
The RemedyLogic AI MRI Lumbar Spine Reader is an image post-processing software that leverages artificial intelligence to provide quantitative measurements from lumbar spine MRI scans. Its primary aim is to assist clinicians by automating feature segmentation and measurement, supporting documentation and visualization, and has demonstrated accuracy through non-clinical performance testing against radiologist-derived ground truth.
Summary
The RemedyLogic AI MRI Lumbar Spine Reader has received substantial equivalence clearance, enabling its market release as a Class II Medical Image Management and Processing System. This regulatory approval was based on a comprehensive assessment of the device's intended use, technological characteristics, and operational principles, confirming its comparability to existing legally marketed medical devices. The device functions as image post-processing and measurement software, designed to extract quantitative spine measurements from previously acquired DICOM lumbar spine Magnetic Resonance images. It assists radiologists and spine specialists by providing functionalities for feature segmentation, measurement, and export of results, aiding in visualization and documentation, though it does not provide diagnoses or treatment recommendations. Its non-clinical performance, including a study validating outputs against radiologist-established ground truth, demonstrated the device's accuracy and adherence to relevant industry and cybersecurity standards.
AI Regulatory Concerns
Powered by
Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.
Keywords
Device Metadata
Relevant Clinical Questions
- Q1. What specific anatomical features or measurements does the RemedyLogic AI MRI Lumbar Spine Reader quantify, and what are their clinical significances?; How does the AI algorithm within the device perform feature segmentation and measurement, and what are its limitations regarding image quality or pathological variations?; What was the methodology for establishing "ground truth" by radiologists in the non-clinical performance testing, and what was the inter-reader variability among those radiologists?; Are there plans for clinical validation studies involving patient outcomes or multi-center evaluations to further assess the device's utility in real-world settings?; Given its classification as an aid, what specific steps are integrated into the device's workflow to ensure users verify outputs and apply their medical judgment effectively?
Risk Classification
ESL AnalysisFDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Post-§524B but no clear network capability detected
Learn how Parasoft automates IEC 62304 compliance testing →Cybersecurity Evidence
Powered by SBOMator™Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.
Supply Chain BOM Evidence
Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.
Analysis:
• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.
• Evidence of ML-BOM, OBOM detected in AI-generated device summary.
• SBOM not mentioned in AI-generated device summary. Under §524B (effective Oct 2023), cyber devices must provide a SBOM.
• Not detected in AI-generated device summary: SBOM, SaaSBOM, HBOM, CBOM, VDR/VEX. These may be present in the full FDA submission.
Preparing a similar submission?
ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.
Assess Your Readiness →Or contact ESL directly